2-(4-chlorophenyl)-N-[6-(2-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazol-2-yl]-6-oxo-1H-pyrimidine-5-carboxamide

C22H15ClN6O3S — CID 108809594

IUPAC2-(4-chlorophenyl)-N-[6-(2-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazol-2-yl]-6-oxo-1H-pyrimidine-5-carboxamide
SMILESCOc1ccccc1-c1csc2nc(NC(=O)c3cnc(-c4ccc(Cl)cc4)[nH]c3=O)nn12
InChIInChI=1S/C22H15ClN6O3S/c1-32-17-5-3-2-4-14(17)16-11-33-22-27-21(28-29(16)22)26-20(31)15-10-24-18(25-19(15)30)12-6-8-13(23)9-7-12/h2-11H,1H3,(H,24,25,30)(H,26,28,31)
InChIKeyCTLMCYITQGXTRV-UHFFFAOYSA-N
MW478.92 g/mol
LogP4.12
Rot. Bonds5

About 2-(4-chlorophenyl)-N-[6-(2-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazol-2-yl]-6-oxo-1H-pyrimidine-5-carboxamide

2-(4-chlorophenyl)-N-[6-(2-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazol-2-yl]-6-oxo-1H-pyrimidine-5-carboxamide (PubChem CID 108809594) has the molecular formula C22H15ClN6O3S and a molecular weight of 478.92 g/mol. Its IUPAC name is 2-(4-chlorophenyl)-N-[6-(2-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazol-2-yl]-6-oxo-1H-pyrimidine-5-carboxamide.

Molecular Properties

Compound Name2-(4-chlorophenyl)-N-[6-(2-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazol-2-yl]-6-oxo-1H-pyrimidine-5-carboxamide
PubChem CID108809594
Molecular FormulaC22H15ClN6O3S
Molecular Weight478.92 g/mol
Exact Mass478.06
IUPAC Name2-(4-chlorophenyl)-N-[6-(2-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazol-2-yl]-6-oxo-1H-pyrimidine-5-carboxamide
SMILESCOc1ccccc1-c1csc2nc(NC(=O)c3cnc(-c4ccc(Cl)cc4)[nH]c3=O)nn12
InChIInChI=1S/C22H15ClN6O3S/c1-32-17-5-3-2-4-14(17)16-11-33-22-27-21(28-29(16)22)26-20(31)15-10-24-18(25-19(15)30)12-6-8-13(23)9-7-12/h2-11H,1H3,(H,24,25,30)(H,26,28,31)
InChIKeyCTLMCYITQGXTRV-UHFFFAOYSA-N
XLogP4.12
TPSA114.27 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500478.92
LogP ≤ 54.12
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Analyze 2-(4-chlorophenyl)-N-[6-(2-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazol-2-yl]-6-oxo-1H-pyrimidine-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-(4-chlorophenyl)-N-[6-(2-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazol-2-yl]-6-oxo-1H-pyrimidine-5-carboxamide?
The IUPAC name of 2-(4-chlorophenyl)-N-[6-(2-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazol-2-yl]-6-oxo-1H-pyrimidine-5-carboxamide (CID 108809594) is 2-(4-chlorophenyl)-N-[6-(2-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazol-2-yl]-6-oxo-1H-pyrimidine-5-carboxamide.
What is the SMILES notation for 2-(4-chlorophenyl)-N-[6-(2-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazol-2-yl]-6-oxo-1H-pyrimidine-5-carboxamide?
The canonical SMILES for 2-(4-chlorophenyl)-N-[6-(2-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazol-2-yl]-6-oxo-1H-pyrimidine-5-carboxamide is COc1ccccc1-c1csc2nc(NC(=O)c3cnc(-c4ccc(Cl)cc4)[nH]c3=O)nn12.
What is the InChIKey of 2-(4-chlorophenyl)-N-[6-(2-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazol-2-yl]-6-oxo-1H-pyrimidine-5-carboxamide?
The InChIKey is CTLMCYITQGXTRV-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H15ClN6O3S/c1-32-17-5-3-2-4-14(17)16-11-33-22-27-21(28-29(16)22)26-20(31)15-10-24-18(25-19(15)30)12-6-8-13(23)9-7-12/h2-11H,1H3,(H,24,25,30)(H,26,28,31).
What are the key properties of 2-(4-chlorophenyl)-N-[6-(2-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazol-2-yl]-6-oxo-1H-pyrimidine-5-carboxamide?
2-(4-chlorophenyl)-N-[6-(2-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazol-2-yl]-6-oxo-1H-pyrimidine-5-carboxamide has a molecular weight of 478.92 g/mol, XLogP of 4.12, 5 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(4-chlorophenyl)-N-[6-(2-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazol-2-yl]-6-oxo-1H-pyrimidine-5-carboxamide is sourced from PubChem (CID 108809594), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).